NCT05152303View on ClinicalTrials.gov

A Study of Remimazolam Tosilate for Sedation in the ICU

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 12, 2022

Primary Completion Date

April 2, 2023

Study Completion Date

April 19, 2023

Conditions
Sedation in the ICU
Interventions
DRUG

Remimazolam Tosilate

Loading dose: 0.08mg/kg IV of Remimazolam Tosilate, Maintenance dose: IV remimazolam tosilate, dose range 0-2.0mg/kg/h, increment or decrement of 0.1mg/kg/h

DRUG

Remimazolam Tosilate

Loading dose: 0.08mg/kg, Drug: Propofol Injection Maintenance dose: IV remimazolam tosilate, dose range 0-2.0mg/kg/h, increment or decrement of 0.2mg/kg/h IV of Propofol Injection

Trial Locations (1)

510060

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Fujian Shengdi Pharmaceutical Co., Ltd.

INDUSTRY